How we found $72M in dormant revenue inside a 40-community PE senior living portfolio.

What we found in the 40-community portfolio.

A mid-market PE fund engaged Innovation Park 18 months post-acquisition. The thesis at acquisition had assumed steady referral growth across the portfolio. Eighteen months in, the aggregate referral revenue line was flat. The CEO of the operating company couldn't explain why. The CFO had built a board deck that said "macro headwinds" because no better explanation existed. The fund's next quarterly board meeting was in 90 days.

We ran the Revenue Lens scan against the operator's referral history — every relationship that had produced a discharge, an admission, or a community-organization placement over the previous 36 months. The output was a dormancy concentration map. Three structural findings surfaced on the first pass:

• Referral attribution was undocumented across all 40 communities. The operator's CRM tracked who came in, not where they came from after the second touchpoint. Discharge-planner relationships were maintained verbally by community executive directors — and walked out the door every time one of them turned over.
• Pricing had not been renegotiated since acquisition. Eighteen months of cost inflation, zero rate adjustment with hospital systems or insurer-aligned referral programs.
• The three largest historical referral relationships had gone dormant — silently — over the previous six months. All three were specific named hospital systems whose discharge volume had dropped by 70%+ without anyone at the operator noticing because the aggregate roll-up was stable.

Per community, that's roughly $1.8M of additional ARR the operating company was structurally positioned to capture but wasn't. No new marketing. No new headcount. No new acquired relationships. The revenue existed — the system to see it didn't.

The numbers looked fine in the rollup. The branch executive saw their own numbers. The rollup hid the rest. The operating partner got a single line item on a sheet with no way to interrogate it.— Tyler Opsahl · diagnostic note, week 3

Why aggregate metrics hide dormant revenue — and always will.

Multi-location operators measure referral revenue at the rollup. Communities, sites, branches each report monthly volume, and the operator aggregates upward. The rollup is what the board sees. The rollup is what the operating partner reviews. The rollup is what the diligence team reads.

The rollup is structurally incapable of surfacing concentration risk. Two communities can show identical referral volume — one with a healthy diversified referrer base, the other with two referrers carrying 80% of the volume. The rollup numbers are identical. The risk profiles are not. When one of those two referrers goes quiet, the second community's revenue collapses; the first community is unaffected. By the time the rollup detects it, the relationship that went quiet has been dormant for 6–12 months, and reactivation costs are 4–6× what they would have been at the 90-day mark.

This is why a third of historically active referrers across the dataset have sent zero in the last 90 days, and nobody is alerted. Aggregate metrics are designed to measure outcome. Dormancy is a leading indicator that requires measuring the relationship graph directly. There is no clever dashboard you can build on top of aggregate volume data that will surface dormancy concentration — the data structure itself is wrong.

How the Revenue Lens scan actually works.

The diagnostic runs over 60 days in five sequenced phases. Each phase produces an artifact you can read — not a slide. The artifacts compound: the Week 4 output feeds Week 6, which feeds the Week 10 board-ready report.

The AI scanning layer is what makes this run at portfolio scale in 60 days instead of per-site in 6 months. Agents map the relationship graph, time-stamp last-active signals, calculate concentration, and surface the dormancy concentration map without humans pivoting tables. The methodology is the product; the AI is the way it scales across 40 sites.

The concentration-risk number nobody calculated.

Inside the $72M portfolio, the concentration risk was severe and silent. The top 15% of historically active referrers across the portfolio accounted for 78% of historical volume. A third of that group — roughly 5% of all referrers — had sent nothing in the last 90 days. Translating that into revenue: ~$31M of the $72M dormant total was concentrated in fewer than 60 named relationships across 40 communities.

This is the number the board needed. Not "referral revenue is flat" — but "60 named relationships, listed by name and location and historical volume, are quiet and need protocoled reactivation in the next 90 days." That converts an inexplicable flat line into an actionable, defensible operating plan with line items the CFO can track quarterly.

The 6.2× location variance — same referrer base, different operator behavior.

The most actionable single finding in the diagnostic was the variance number. Across the 40 communities, top-of-cohort and bottom-of-cohort communities differed by 6.2× on referral-to-admission conversion on the same referrer base. Communities sharing identical hospital catchment areas, identical insurer-aligned referral programs, and identical pricing structures were producing radically different conversion outcomes from the same input population.

This variance is operator behavior, not market position. The top-cohort communities had executive directors who maintained discharge-planner relationships on a 72-hour cadence after every referral. The bottom-cohort communities had executive directors who treated referrers as one-time transactions. Same brand, same training playbook, same referral incentives — wildly different outcomes because the cadence wasn't measured and wasn't enforced.

Standardizing the 72-hour signal protocol across the portfolio is what closes that variance. It's the cheapest, fastest, most defensible intervention in the entire engagement — and it's available because the variance was measured.

What the reactivation protocol actually does.

For each of the top-15 named dormant relationships, the engagement produces a reactivation protocol with five components:

1. Last-active context. When did the relationship last produce, what was the last signal, what changed.
2. Named contact path. The specific human at the referring organization and the specific human at the operator who is responsible for re-engaging — not a department, not a role, a named person.
3. 72-hour signal window. First outreach within 72 hours of the protocol activation, with a defined script tied to last-active context.
4. 30-day cadence. Follow-up sequence with specific touch types over the first 30 days — not a CRM drip, a coordinator-led sequence with discretion.
5. Recovery measurement. What "reactivated" means for this specific relationship, with a measurable threshold tied to historical volume.

Why McKinsey can't run this engagement at this price.

If you're evaluating us against McKinsey's Provider Revenue Excellence practice, here is the honest comparison. McKinsey serves 500+ physician-system and large operator clients with $1.8M–$5M engagements over 6–12 months. Their analyst pool is staffed against engagements that produce strategy decks, not implementation protocols. Their economics structurally do not permit a 60-day, $25K diagnostic for a 40-community operator.

That isn't a flaw. It's the natural shape of a Big-Four engagement. For a $5B PE healthcare fund running due diligence on a $500M acquisition, McKinsey is the right call. For a 40-community portco that needs a defensible referral revenue line in 90 days, McKinsey is the wrong tool — not because they're bad at the work, but because the engagement economics force them to operate at a different scale.

We sit below their economic floor on purpose. Below 50 locations or $250M EBITDA, the operator economics make us the rational choice. Above that, McKinsey is.

How the engagement is structured.

The Revenue Lens diagnostic is a fixed-scope fee for the 60-day engagement, plus a share of revenue actually recovered through the engagement over the 12 months following the diagnostic — attributable to interventions named in the report. The recovery share is set by scope and how much of the implementation we run alongside your team.

For Referral Partnership Revenue Recovery and Revenue Optimization engagements for mid-sized businesses ($30M+ revenue), the 3× fee recovery guarantee is the asymmetric risk floor: if the diagnostic does not surface at least recoverable revenue worth at least three times our fee, we keep working at no additional fee until we do. Across 200+ engagements we have never failed to clear that floor. The qualification call before the engagement confirms expected fit — if your portfolio is unlikely to surface that level of recovery, we say so before you commit, not after.

For PE operating partners specifically, the engagement is invoiced and structured to be diligence-friendly. Engagement letter specifies attribution methodology line by line so there is no dispute later. Mutual NDA before any data exchange. References available on request.

How to start.

If you operate a PE healthcare portfolio with a flat referral line — or run a 1–40 location operator with a referrer base you can't see clearly — here is the fastest path to a real answer. No leap. A stair.